Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03532581 · ClinicalTrials.gov registry record · NA

Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT03532581 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03532581, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.

Interventions

  • PROCEDURE Lymphangiography
  • OTHER Indocyanine Green Solution

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2018-04-23
Est. Completion 2023-03-07
Phase NA

What the Registry Record Tells You About NCT03532581

The ClinicalTrials.gov registry entry for NCT03532581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lymphangiography is the first listed.

NCT03532581 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03532581 about?

NCT03532581 is a clinical study titled "Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery". This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.

What is the current status of trial NCT03532581?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-04-23. Estimated completion is 2023-03-07.

What interventions are being tested in trial NCT03532581?

The interventions under investigation include: Lymphangiography (PROCEDURE), Indocyanine Green Solution (OTHER).

Who is sponsoring clinical trial NCT03532581?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.